Teva Pharma (TEVA) volatility increases on Mylan (MYL) granted FDA approval of Copaxone
Go back to Teva Pharma (TEVA) volatility increases on Mylan (MYL) granted FDA approval of Copaxone| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 39.19 +0.66 (1.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.53 | 52 Week High | $66.55 | |||
| Open | $38.96 | 52 Week Low | $37.82 | |||
| Day High | $39.70 | P/E | N/A | |||
| Day Low | $38.71 | EPS | $0.00 | |||
| Volume | 5,521,239 | |||||
